- 01
Novartis AG
NOVNSIXSwitzerland
$286.3B
+4.7% 1W·+14.6% 1Y
- 02
AstraZeneca PLC
AZNNYSEUnited Kingdom
$256.5B
— 1W·-3.2% 1Y
- 03
Thermo Fisher Scientific Inc.
TMONYSEUnited States
$255.1B
+4.9% 1W·+28.0% 1Y
- 04
Kite Pharma (Gilead Sciences)
GILDNASDAQUnited States
$193.7B
+3.3% 1W·+27.2% 1Y
- 05
Vertex Pharmaceuticals Inc.
VRTXNASDAQUnited States
$126.6B
-2.0% 1W·+19.9% 1Y
- 06
Bristol-Myers Squibb Company (BMS)
BMYNYSEUnited States
$122.0B
+1.1% 1W·+37.0% 1Y
- 07
WuXi AppTec Co., Ltd.
02359HKEXChina
$75.9B
-5.7% 1W·+93.5% 1Y
- 08
Boston Scientific
BSXNYSEUnited States
$64.3B
+3.9% 1W·-55.3% 1Y
- 09
Lonza Group AG
LONNSIXSwitzerland
$51.2B
+5.6% 1W·+5.0% 1Y
- 10
GenScript Biotech Corporation
1548HKEXChina
$9.7B
-21.5% 1W·+109.0% 1Y
- 11
Legend Biotech Corporation
LEGNNASDAQUnited States
$3.6B
-0.8% 1W·-42.2% 1Y
- 12
Sarepta Therapeutics Inc.
SRPTNASDAQUnited States
$1.8B
-4.2% 1W·-24.0% 1Y
Mostrando 1–12 de 12